Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 755 All time
- Disclosed funding
- $25.4B 617 disclosed amounts
- Median round
- $15.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| R RyloCompany profile Provides AI-powered communication tools for the Deaf and hard-of-hearing community Provides AI-powered communication tools for the Deaf and hard-of-hearing community | $85M | Growth | Healthtech | United States | Investors | |
| EB Element BiosciencesCompany profile Develops genomic and multiomic sequencing platforms for research, translational science, and diagnostics Develops genomic and multiomic sequencing platforms for research, translational science, and diagnostics | $175M | Series ESeries C+ | Healthtech, Biotech | United States | Investors | |
| TP Membership club dedicated to human flourishing and wellness | $5M | Undisclosed | Healthtech, Consumer | United States | Investors Andrew BoggsAneil Mallavarapu +25Ankush GeraBen ArnbergElaine GlassEmmet PeppersJacqui BishopJoshua DouglasJP NewmanKwiri YangLinea AveyManish ChandraMatt EggersMatt MovalsonMatt MullenwegMelissa TauntonMichael FishmanMichael HeinrichMichael SolomonMimi AyeRavi BhojwaniScott FaberShaunda BrownSpencer KayeTim FerrissVishal GurbuxaniZander Rafael | |
| S Offers accelerated, affordable training for healthcare careers | $55M | Series CSeries C+ | Healthtech | United States | Investors | |
| CT City TherapeuticsCompany profile City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas. City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas. | $99.5M | Series B | Healthtech, Biotech | United States | Investors | |
| OP Develops RNAi therapeutics for various diseases | ₩110B | StrategicUndisclosed | Healthtech, Biotech | South Korea | Investors | |
| C CereVascCompany profile Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases | $85M | Series CSeries C+ | Healthtech | United States | Investors | |
| S Provides healthcare management platform for outpatient providers | £30M | Series CSeries C+ | Healthtech | United Kingdom | Investors | |
| AB ARTAN BioCompany profile Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions | $200K | Seed | Healthtech, Biotech | United States | Investors | |
| FH Flok HealthCompany profile AI-operated digital physiotherapy clinic delivering autonomous musculoskeletal care pathways via mobile app AI-operated digital physiotherapy clinic delivering autonomous musculoskeletal care pathways via mobile app | $12.5M | Series A | Healthtech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →